Sheff used to move biotech and pharma stocks- but no longer does.
I follow his trades and SHORT his recommendations and have done very well over the last 12 months!
No dirty mexicans left to work or eat at CMG
Got in at .95 on your article and love it!
ATNM - no reverse split gimmicks, NDA submitted for Phase III cancer drug for Lukemia that has 100% response rate in phase II trials. 30M cash- no debt.
You won't be GAMBLING like here...
AEZS next KBIO - uber low float squeeze
based on technicals (which is about all there is to go on here for now), some recovery in near term maybe?